Back to User profile » Dr Federica Zoratto

Papers published by Dr Federica Zoratto:

Angiogenesis and antiangiogenic agents in cervical cancer

Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S

OncoTargets and Therapy 2014, 7:2237-2248

Published Date: 3 December 2014

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S

OncoTargets and Therapy 2013, 6:1761-1769

Published Date: 29 November 2013

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S

Cancer Management and Research 2013, 5:377-385

Published Date: 19 November 2013

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S

Therapeutics and Clinical Risk Management 2013, 9:457-462

Published Date: 11 November 2013

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer

Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S

OncoTargets and Therapy 2012, 5:199-211

Published Date: 24 September 2012